Carolyn A Cohen
Overview
Explore the profile of Carolyn A Cohen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
434
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jia J, Cohen C, Gu H, McLean M, Varadarajan R, Bhandari N, et al.
Nat Commun
. 2024 Sep;
15(1):8227.
PMID: 39300094
No abstract available.
2.
Cohen C, Leung N, Kaewpreedee P, Lee K, Jia J, Cheung A, et al.
Nat Commun
. 2024 Aug;
15(1):7358.
PMID: 39191745
Whole virion inactivated vaccine CoronaVac (C) and Spike (S) mRNA BNT162b2 (B) vaccines differ greatly in their ability to elicit neutralizing antibodies but have somewhat comparable effectiveness in protecting from...
3.
Jia J, Cohen C, Gu H, McLean M, Varadarajan R, Bhandari N, et al.
Nat Commun
. 2024 Apr;
15(1):3210.
PMID: 38615070
Cross-reactive antibodies with Fc receptor (FcR) effector functions may mitigate pandemic virus impact in the absence of neutralizing antibodies. In this exploratory study, we use serum from a randomized placebo-controlled...
4.
Rowntree L, Cohen C, Valkenburg S
Nat Immunol
. 2024 Jan;
25(1):7-8.
PMID: 38168958
No abstract available.
5.
Rosa Duque J, Cheng S, Cohen C, Leung D, Wang X, Mu X, et al.
World J Pediatr
. 2023 Dec;
20(4):353-370.
PMID: 38085470
Background: Optimising the immunogenicity of COVID-19 vaccines to improve their protection against disease is necessary. Fractional dosing by intradermal (ID) administration has been shown to be equally immunogenic as intramuscular...
6.
Leung N, Cheng S, Cohen C, Martin-Sanchez M, Au N, Luk L, et al.
Lancet Microbe
. 2023 Aug;
4(9):e670-e682.
PMID: 37549680
Background: Few trials have compared homologous and heterologous third doses of COVID-19 vaccination with inactivated vaccines and mRNA vaccines. The aim of this study was to assess immune responses, safety,...
7.
Leung D, Cohen C, Mu X, Rosa Duque J, Cheng S, Wang X, et al.
Front Immunol
. 2023 Mar;
14:1106837.
PMID: 36949953
Introduction: Two doses of inactivated SARS-CoV-2 vaccine CoronaVac cannot elicit high efficacy against symptomatic COVID-19, especially against the Omicron variant, but that can be improved by a third dose in...
8.
Mu X, Cohen C, Leung D, Rosa Duque J, Cheng S, Chung Y, et al.
Signal Transduct Target Ther
. 2022 Dec;
7(1):397.
PMID: 36517469
The high effectiveness of the third dose of BNT162b2 in healthy adolescents against Omicron BA.1 has been reported in some studies, but immune responses conferring this protection are not yet...
9.
Rosa Duque J, Wang X, Leung D, Cheng S, Cohen C, Mu X, et al.
Nat Commun
. 2022 Aug;
13(1):4798.
PMID: 35970832
No abstract available.
10.
Rosa Duque J, Wang X, Leung D, Cheng S, Cohen C, Mu X, et al.
Nat Commun
. 2022 Jun;
13(1):3700.
PMID: 35764637
We present an interim analysis of a registered clinical study (NCT04800133) to establish immunobridging with various antibody and cellular immunity markers and to compare the immunogenicity and reactogenicity of 2-dose...